| Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity J Vassileva, S Georgiev, E Martin, R Gonzalez, L Segala Drug and alcohol dependence 114 (2-3), 194-200, 2011 | 50 | 2011 |
| HIV-negative cryptococcal meningoencephalitis results in a persistent frontal-subcortical syndrome K Traino, J Snow, L Ham, A Summers, L Segalà, T Shirazi, N Biassou, ... Scientific reports 9 (1), 18442, 2019 | 12 | 2019 |
| Clinical evaluation of sibling pairs with gaucher disease discordant for parkinsonism G Lopez, A Steward, E Ryan, C Groden, E Wiggs, L Segalà, ... Movement Disorders 35 (2), 359-365, 2020 | 11 | 2020 |
| Childhood symptoms of ADHD and impulsivity in abstinent heroin users L Segalà, G Vasilev, I Raynov, R Gonzalez, J Vassileva Journal of dual diagnosis 11 (3-4), 174-178, 2015 | 8 | 2015 |
| Medical Symptom Validity Test (MSVT) profiles in individuals being evaluated for Alzheimer’s disease J Snow, L Segalà, L Ham, KA Traino, AC Summers, M McGwier, E Page, ... The Clinical Neuropsychologist 36 (6), 1328-1351, 2022 | 4 | 2022 |
| The relationship between self-reported ADHD symptoms and drug addiction on three measures of impulsivity and decision-making L Segala Adler School of Professional Psychology, 2014 | 1 | 2014 |
| The Cognitive Profile of Gaucher Disease Type I L Ham, A Spiegel, E Wiggs, G Lopez, E Ryan, E Sidransk, L Segala CLINICAL NEUROPSYCHOLOGIST 36 (4), 752-752, 2022 | | 2022 |
| The Cognitive Phenotyping of McCune-Albright Syndrome: A Case Series (P2. 1-021) L Ham, L Segalà, G Norato, M Gregory, A Boyce, M Collins, J Snow Neurology 92 (15 Supplement), 2019 | | 2019 |
| Classification of neurocognitive impairment in Spanish speaking Parkinson's disease patients S Anderson, C Bermudez, N Sun-Suslow, L Segala, H Moore, C Singer, ... MOVEMENT DISORDERS 32, 2017 | | 2017 |
| Does hypertension moderate cognition in Parkinson's disease? L Segala, K McInerney, J Rooks, S Anderson, N Sun-Suslow, ... MOVEMENT DISORDERS 32, S45-S45, 2017 | | 2017 |
| Deep brain stimulation for Parkinson's disease: Short-term outcomes, referral patterns and health disparities DG Di Luca, V Velez-Aldahondo, W Jermakowicz, L Segala, H Moore, ... MOVEMENT DISORDERS 32, S60-S60, 2017 | | 2017 |
| The role of social support on cognitive functioning after deep brain stimulation in Parkinson's disease N Sun-Suslow, K McInerney, C Bermudez, S Anderson, L Segala, ... MOVEMENT DISORDERS 32, S46-S46, 2017 | | 2017 |
| Does exposure to toxins influence cognition in Parkinson's disease? K McInerney, C Bermudez, L Segala, N Sun-Suslow, J Rooks, ... MOVEMENT DISORDERS 32, S47-S48, 2017 | | 2017 |
| Moderate Caffeine Intake and Verbal Memory in Multiple Sclerosis: A Pilot Study L Segalà, M Forte, MR Ortega, S Delgado, K Rammohan, BE Levin Journal of caffeine research 6 (3), 134-138, 2016 | | 2016 |
| A-30ADHD Assessed with Self-Report Does not Predict Neurocognitive Performance in Abstinent Opiate and Amphetamine Users L Segalà, G Vasilev, K Bozgunov, R Naslednikova, I Raynov, R Gonzalez, ... Archives of Clinical Neuropsychology 28 (6), 518-626, 2013 | | 2013 |
| ADHD Assessed with Self-Report Does not Predict Neurocognitive Performance in Abstinent Opiate and Amphetamine Users L Segala, G Vasilev, K Bozgunov, R Naslednikova, I Raynov, R Gonzalez, ... ARCHIVES OF CLINICAL NEUROPSYCHOLOGY 28 (6), 529-529, 2013 | | 2013 |
